# Rebecca Lin

> Rebecca Lin is a Series A investor at Eight Roads Ventures backing Pharmaceutical and Medical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Eight Roads Ventures](https://shizune.co/investors/profile/eight-roads-ventures)
- Location: Jingan, China
- Total investments: 2
- Last investment: Jul 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/rebecca-lin-b08167/

Rebecca Lin is a Series A investor at Eight Roads Ventures in Jingan focused on Pharmaceutical and Medical. Rebecca Lin is based out of Jingan, Shanghai and is the Senior Partner and Co-Head of Eight Roads Ventures China Healthcare. Rebecca previously worked at CMT ChinaValue Capital Partners. Rebecca Lin attended the Wharton School of Business, University of Pennsylvania.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Pharmaceutical | 2 | 100% |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Citrine Medicine | Citrine Medicine is a rare disease-focused pharmaceutical firm. | $80M | Series A | Jul 13, 2020 |  |
| RareStone Group (Previously Citrine Medicine) | Citrine Medicine is a rare disease-focused pharmaceutical firm. | $80M | Series A | Jul 13, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [3H Health Investment](https://shizune.co/investors/profile/3h-health-investment) — VC Fund, 2 deals together
- [F-Prime](https://shizune.co/investors/profile/f-prime-capital-partners) — VC Fund, 2 deals together
- [Quan Capital](https://shizune.co/investors/profile/quan-capital) — VC Fund, 2 deals together
- [Vivo Capital](https://shizune.co/investors/profile/vivo-capital) — VC Fund, 2 deals together
- [Wu Capital](https://shizune.co/investors/profile/wu-capital) — VC Fund, 2 deals together

## About Eight Roads Ventures

VC Fund · London, United Kingdom

Eight Roads Ventures is a global venture capital firm managing $11bn of assets across offices in the UK, China, India, Japan, and the US. Together with our associated funds, including our US sister fund F-Prime Capital, our 50-year history of investing includes partnerships with over 500 companies such as Alibaba, AppsFlyer, Chewy, Fareye, Fever,Flywire, Fireblocks, Funnel.io, Gloat, Hibob, Icertis, Neo4j, Otrium, Owkin, Paidy, Spendesk, Tibber, Toast, Wallapop and Xoom.

5 contacts available at Eight Roads Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Aditya Systla | Partner | https://shizune.co/investors/profile/aditya-gurunath-systla |
| Gordon Zhang | Vice President & Principal | https://shizune.co/investors/profile/gordon-zhang |
| Jarlon Tsang | Managing Partner, Head of China | https://shizune.co/investors/profile/jarlon-tsang |
| Michael Treskow | Partner | https://shizune.co/investors/profile/michael-treskow |
| Prem Pavoor | Partner | https://shizune.co/investors/profile/prem-pavoor |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Rebecca Lin invest in?

Rebecca Lin invests primarily in Pharmaceutical, Medical and Health Care startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Rebecca Lin last invest?

The most recent investment recorded for Rebecca Lin closed in Jul 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co